NO20020303L - Flerdose-erytropoietinpreparater - Google Patents

Flerdose-erytropoietinpreparater

Info

Publication number
NO20020303L
NO20020303L NO20020303A NO20020303A NO20020303L NO 20020303 L NO20020303 L NO 20020303L NO 20020303 A NO20020303 A NO 20020303A NO 20020303 A NO20020303 A NO 20020303A NO 20020303 L NO20020303 L NO 20020303L
Authority
NO
Norway
Prior art keywords
dose erythropoietin
dose
erythropoietin
formulations
phenoxyethanol
Prior art date
Application number
NO20020303A
Other languages
English (en)
Norwegian (no)
Other versions
NO20020303D0 (no
Inventor
Atef Gayed
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20020303D0 publication Critical patent/NO20020303D0/no
Publication of NO20020303L publication Critical patent/NO20020303L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1816Erythropoietin [EPO]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
NO20020303A 1999-07-22 2002-01-21 Flerdose-erytropoietinpreparater NO20020303L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19821699P 1999-07-22 1999-07-22
PCT/US2000/040446 WO2001007075A2 (en) 1999-07-22 2000-07-21 Multi-dose erythropoietin formulations

Publications (2)

Publication Number Publication Date
NO20020303D0 NO20020303D0 (no) 2002-01-21
NO20020303L true NO20020303L (no) 2002-03-21

Family

ID=22732468

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20020303A NO20020303L (no) 1999-07-22 2002-01-21 Flerdose-erytropoietinpreparater

Country Status (25)

Country Link
US (1) US7432360B2 (cs)
EP (1) EP1200115B9 (cs)
JP (1) JP2003517462A (cs)
KR (1) KR100693263B1 (cs)
CN (2) CN1371284A (cs)
AT (1) ATE304863T1 (cs)
AU (1) AU777397B2 (cs)
BR (1) BR0012667A (cs)
CA (1) CA2378945C (cs)
CZ (1) CZ302750B6 (cs)
DE (1) DE60022759T2 (cs)
DK (1) DK1200115T3 (cs)
EA (1) EA006220B1 (cs)
EE (1) EE200200037A (cs)
ES (1) ES2248110T3 (cs)
HK (1) HK1050318A1 (cs)
HR (1) HRP20020159B1 (cs)
HU (1) HUP0202246A3 (cs)
IL (2) IL147755A0 (cs)
NO (1) NO20020303L (cs)
NZ (1) NZ516735A (cs)
PL (1) PL202945B1 (cs)
RS (1) RS50355B (cs)
WO (1) WO2001007075A2 (cs)
ZA (1) ZA200200742B (cs)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003520777A (ja) 1999-07-22 2003-07-08 アベンティス・ファーマスーティカルズ・インコーポレイテツド 防腐医薬製剤
ATE291436T2 (de) 2000-05-15 2005-04-15 Hoffmann La Roche Flüssige arzneizubereitung enthaltend ein erythropoietin derivat
US7148211B2 (en) 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
CA2561222A1 (en) * 2004-03-26 2005-10-20 Janssen Pharmaceutica, N.V. Combination dosing regimen for erythropoietin
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
WO2006081969A1 (de) * 2005-02-03 2006-08-10 Clariant Produkte (Deutschland) Gmbh Konservierungsmittel
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
KR101805087B1 (ko) 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
EP3364944B1 (en) * 2015-10-22 2024-06-12 Iltoo Pharma Pharmaceutical compositions of il-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
JP2532025B2 (ja) * 1993-07-23 1996-09-11 株式会社林原生物化学研究所 新リンホカインiiiを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
US5968899A (en) * 1994-06-03 1999-10-19 Tsumura & Co. Medicinal compositions of peptides with EACA or tranexamic acid for enhanced mucosal absorption
AU1750997A (en) * 1996-01-19 1997-08-11 Eli Lilly And Company Obesity protein formulations
US6261545B1 (en) * 1996-09-13 2001-07-17 Advanced Medicine Research Institute Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders
JPH1112193A (ja) * 1997-06-19 1999-01-19 Sankyo Co Ltd ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine

Also Published As

Publication number Publication date
CZ2002264A3 (cs) 2002-06-12
KR100693263B1 (ko) 2007-03-13
BR0012667A (pt) 2002-07-02
EP1200115B9 (en) 2006-01-18
NO20020303D0 (no) 2002-01-21
AU7137400A (en) 2001-02-13
CN101091792A (zh) 2007-12-26
AU777397B2 (en) 2004-10-14
YU4702A (sh) 2005-06-10
RS50355B (sr) 2009-11-10
WO2001007075A2 (en) 2001-02-01
CZ302750B6 (cs) 2011-10-19
HUP0202246A2 (en) 2002-10-28
EP1200115B1 (en) 2005-09-21
KR20020011143A (ko) 2002-02-07
EP1200115A2 (en) 2002-05-02
EA006220B1 (ru) 2005-10-27
EA200200073A1 (ru) 2002-08-29
CN1371284A (zh) 2002-09-25
CA2378945A1 (en) 2001-02-01
US7432360B2 (en) 2008-10-07
NZ516735A (en) 2004-01-30
IL147755A (en) 2009-11-18
ES2248110T3 (es) 2006-03-16
HRP20020159A2 (en) 2003-06-30
JP2003517462A (ja) 2003-05-27
CA2378945C (en) 2010-02-23
HUP0202246A3 (en) 2010-01-28
WO2001007075A3 (en) 2001-10-04
HRP20020159B1 (en) 2007-08-31
US20050267033A1 (en) 2005-12-01
EE200200037A (et) 2003-04-15
HK1050318A1 (zh) 2003-06-20
ZA200200742B (en) 2003-06-25
DE60022759T2 (de) 2006-06-22
DE60022759D1 (de) 2006-02-02
PL353569A1 (en) 2003-12-01
DK1200115T3 (da) 2006-01-16
ATE304863T1 (de) 2005-10-15
PL202945B1 (pl) 2009-08-31
IL147755A0 (en) 2002-08-14

Similar Documents

Publication Publication Date Title
DK0895776T3 (da) Kosmetisk, lysskærmende præparat
DE60010098D1 (de) 28-epirapaloge
HRP20030383B1 (hr) Laktamski spoj
WO2001034646A3 (en) Recombinant gelatins
ATE370748T1 (de) Erythropoietin derivate
DE69907145D1 (de) Haarstyling shampoozusammensetzung
BR0000327B1 (pt) cabeÇa de poÇo.
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
NO20020303D0 (no) Flerdose-erytropoietinpreparater
DK15098A (da) Retningsbestemt mikrofon, især med symmetrisk retningsvirking
TR199800105A2 (xx) Tadlar� kaplanm��, antibakteriyel etkili kinolon t�revlerinin �retimi.
TR200002955T2 (tr) Antitümör aktivitesi olan spisülozin bileşimleri
DE69616074D1 (de) Ara-c derivate
DE60129804D1 (de) Hydrophobierende mikro-emulsionen
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
NO20031673D0 (no) Behandling av kreft
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
DE69705849D1 (de) Herstellung von 3,5-lutidin
DK1173065T3 (da) Anvendelse af cellulosemikrofibriller i fermenterede mælkepræparater
FR2752699B1 (fr) Boitier, du type boitier de maquillage
DE50011910D1 (de) Kosmetische zubereitungen
ES1043491Y (es) Mesa redonda de brazos desplegables.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application